Orthosomnia and consumer sleep technologies: a narrative review and industry-academia perspective of risk factors, safeguards, and technology design recommendations
Publication date: Available online 12 November 2026 Source: Sleep Medicine Reviews Author(s): Elie Gottlieb, Kelly Baron, Cathy Goldstein, Sooyeon Suh, Rebecca Robbins, Shona L. Halson, Massimiliano de Zambotti, Maristella Lucchini, Roy JEM Raymann, Nathaniel F. Watson
Orthosomnia and consumer sleep technologies: a narrative review and industry-academia perspective of risk factors, safeguards, and technology design recommendations. // Sleep Medicine Reviews. – URL: https://www.sciencedirect.com/science/article/pii/S1087079226001693?dgcid=rss_sd_all
Orthosomnia and consumer sleep technologies: a narrative review and industry-academia perspective of risk factors, safeguards, and technology design recommendations. Sleep Medicine Reviews. https://www.sciencedirect.com/science/article/pii/S1087079226001693?dgcid=rss_sd_all
“Orthosomnia and consumer sleep technologies: a narrative review and industry-academia perspective of risk factors, safeguards, and technology design recommendations.” Sleep Medicine Reviews.
@article{article66580,
title = {Orthosomnia and consumer sleep technologies: a narrative review and industry-academia perspective of risk factors, safeguards, and technology design recommendations},
journal = {Sleep Medicine Reviews},
url = {https://www.sciencedirect.com/science/article/pii/S1087079226001693?dgcid=rss_sd_all}
}
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...